European P&C stocks broadly tumbled amid widespread selling during November, as investors kept a wary eye on the newly detected and possibly vaccine-resistant Omicron coronavirus variant.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: